PharmEasy key facts
- Operator of an online drug delivery platform designed to improve the supply chain of pharmaceuticals by completely digitizing the process.
- It has raised $2.3B; the latest was Secondary Transaction - Private in Feb 2025.
- Notable investors include Tiger Global Management, KB Investment, Temasek Holdings, B Capital Group, OrbiMed — 47 tracked in total.
- Status: Privately Held (backing).
Who backs PharmEasy
47+Membership and data by Private Market View
- ·The complete investor list: 47 names
- ·Watch PharmEasy: the Monday email on marks, rounds and moves
PharmEasy funding rounds
No funding rounds for PharmEasy are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
PharmEasy investors
47 investors are on record for PharmEasy, including Tiger Global Management, KB Investment, Temasek Holdings and B Capital Group. By type, the record holds 6 venture capital firms and 3 family offices.
About PharmEasy
Operator of an online drug delivery platform designed to improve the supply chain of pharmaceuticals by completely digitizing the process. The company's application sells medicines and healthcare products and aids in connecting with local pharmacy stores and diagnostic centers to fulfill extensive medical needs, enabling patients to receive healthcare services that are easily available, affordable, and accessible.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Mumbai, India
- Founded
- 2014
- Employees
- 3,939
- Website
- pharmeasy.in/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
PharmEasy doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.